Forget Covid, we have just cemented our place in e
Post# of 148192
Remember, leronlimab is not a “Covid drug”. It is modulating the immune system to temper the body’s response to this viral invader. This will now become the standard of care for critical influenza and ARDS. It saves lives and shortens hospital stays. Leronlimab doesn’t care which virus is causing the problem. Yes, we might have missed “peak Covid” and that sucks but these results are great great news for the company and for the world.
Bring on the expanded protocol and get FDA approval because it will only help to convince the rest of the world what we already know, that leronlimab saves lives and shortens hospital stays.
(Oh, BTW. We might work with a bunch of different types of cancer, NASH, and might even cure HIV in some people)